Arthrocentesis in the Management of Temporomandibular Joint Disorders: Current and Innovative Approaches


Creative Commons License

Duman B., Gedik B., Bokhari S. A. H., DOĞANCALI DEMİRAL G. E., ERDEM M. A.

European Journal of General Dentistry, cilt.15, sa.3, ss.315-322, 2026 (Scopus)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 15 Sayı: 3
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1055/s-0046-1815917
  • Dergi Adı: European Journal of General Dentistry
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.315-322
  • Anahtar Kelimeler: arthrocentesis, bone marrow aspirate concentrate, hyaluronic acid, platelet-rich plasma, temporomandibular joint disorders
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Evet

Özet

Temporomandibular joint disorders (TMDs) affect a substantial proportion of the population and represent the second most common musculoskeletal complaint after chronic low back pain. Arthrocentesis has emerged as an effective, minimally invasive, and cost-efficient treatment option for patients who do not respond adequately to conservative therapies such as nonsteroidal anti-inflammatory drugs, physiotherapy, and occlusal splints. Since its first description by Nitzan in 1991, both the technical aspects of arthrocentesis and the range of intra-articular agents used in conjunction with lavage have evolved considerably. Recent developments include single-needle and modified techniques, image-guided and navigation-assisted approaches, and the use of orthobiologic agents such as platelet concentrates and bone marrow-derived products. This narrative review summarizes contemporary diagnostic imaging and functional assessment methods, modern conservative treatment modalities, current arthrocentesis techniques, and up-to-date evidence on intra-articular pharmacologic and biologic agents. In addition, a pragmatic clinical decision-making framework is outlined to situate arthrocentesis within a stepwise management algorithm for TMDs. Overall, current data support arthrocentesis as a safe and effective option in selected patients; however, heterogeneity in techniques and injection protocols underscores the need for well-designed randomized controlled trials to establish standardized, patient-specific treatment pathways.